Get started
Author

Elif Sertesen

Observed names: E. Sertesen, E. Sertesen Camoz, Elif SERTESEN, Elif Sertesen Camoz, Elif Sertesen Çamöz, Elif Serteşen Camöz, Sertesen Camoz, Elif, Sertesen Çamoz, Elif, Sertesen Çamöz, Elif
Observed institutions: Ankara University, Başkent University, Ankara Onkoloji Eğitim ve Araştırma Hastanesi, Sağlık Bilimleri Üniversitesi, University of Health Sciences, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara Eğitim ve Araştırma Hastanesi
ORCID: 0000-0002-1991-6620
Observed ORCID: 0000-0002-1991-6620
OpenAlex ID: A5028181587
The Role of Artificial Intelligence (ChatGPT-4o) in Supporting Tumor Board Decisions
2025 · Berkan Karabuğa, Cengiz Karaçin, et al. · Journal of Clinical Medicine · 23
PDF
TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease
2023 · Yusuf Yilmaz, Mujdat Zeybel, et al. · Hepatology forum/Hepatology forum (Online) · 18
PDF
Recommendations for Hepatitis B Immunoglobulin and Antiviral Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation
2021 · Mesut Akarsu, Soner Onem, et al. · The Turkish Journal of Gastroenterology · 13
PDF
Evaluating the Effectiveness of the Charlson Comorbidity Index in Predicting Immune Checkpoint Inhibitor-Related Adverse Events
2024 · İlknur Deliktaş Onur, Emel Mutlu, et al. · Immunotherapy · 10
Evaluating the prognostic role of glucose-to-lymphocyte ratio in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors in first line: a study by the Turkish Oncology Group Kidney Cancer Consortium (TKCC)
2025 · Hatice Bolek, Omer Faruk Kuzu, et al. · Clinical & Translational Oncology · 8
PDF
Treatment Patterns and Attrition in Metastatic Renal Cell Carcinoma: Real-Life Experience from the Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database
2024 · Hatice Bölek, Elif Sertesen, et al. · Clinical Genitourinary Cancer · 4
Is the Prognostic Nutritional Index a Novel Prognostic Factor in Patients With Unresectable/Metastatic Gallbladder and Cholangiocarcinoma Receiving Chemotherapy?
2024 · İlknur Deliktaş Onur, Hatice Gülgün Fırat, et al. · Cureus · 4
PDF
Sunitinib in metastatic renal cell carcinoma: clinical outcomes across risk groups in a Turkish Oncology Group Kidney Cancer Consortium
2025 · Hatice Bolek, Omer Faruk Kuzu, et al. · 癌症：英文版 · 3
PDF
Evaluation of sarcopenia’s relationship with overall survival and treatment toxicity in soft tissue sarcomas
2025 · İlknur Deliktaş Onur, Pınar Özdemir Akdur, et al. · Supportive Care in Cancer · 3
Prognostic factors in non-metastatic HER2 ‘low’ and HER2 ‘negative’ breast cancer: single institute experience
2024 · Alper Türkel, Mutlu Doğan, et al. · Wiener klinische Wochenschrift · 3
Real‐world comparison of cabozantinib and sunitinib in advanced non‐clear cell renal cell carcinoma: A multicenter study by the Turkish Oncology Group
2025 · Gökhan Şahin, Esmanur Kaplan Tüzün, et al. · International Journal of Cancer · 2
Impact of first-line tyrosine kinase inhibitor selection on survival outcomes with second-line nivolumab in metastatic renal cell carcinoma
2025 · Omer Faruk Kuzu, Hatice Bolek, et al. · BMC Cancer · 2
PDF
Evaluation of the prognostic effectiveness of liver metastasis volume by volumetric measurement in colorectal cancer
2024 · İlknur Deliktaş Onur, Pınar Özdemir Akdur, et al. · Future Oncology · 2
PDF
FOLFIRI-bevacizumab-induced acute toxic leukoencephalopathy
2023 · Elif Sertesen, Ali Öztaş, et al. · Journal of Oncology Pharmacy Practice · 2
The effect of primary tumour resection on patients with synchronous metastatic colorectal cancer treated with cetuximab‐containing regimens
2022 · Elif Sertesen, Emre Yekedüz, et al. · ANZ Journal of Surgery · 2
Domain-Level Distribution of Pathogenic BRCA1/2 Somatic Mutations Shows No Evidence of Large Subtype-Specific Enrichment in Breast Cancer: A Three-Cohort Analysis Supporting Broad BRCA Testing
2026 · Elif Sertesen Çamöz, Fatih Yıldız, et al. · Genes · 1
Prognostic role of smoking in metastatic renal cell carcinoma in real-world data from the Turkish Oncology Group Kidney Cancer Consortium (TKCC)
2026 · Hatice Bolek, Elif Sertesen Camoz, et al. · Scientific Reports · 1
PDF
Sinonasal Cancers: Single Center Experience
2025 · Elif Sertesen Camoz, Ozturk Ates, et al. · Indian Journal of Otolaryngology and Head & Neck Surgery · 1
PDF
Mucosal, Ocular, and Pulmonary Adverse Events Reported with Datopotamab Deruxtecan: An Indication-Restricted Disproportionality Analysis of the FDA Adverse Event Reporting System
2026 · Osman Bilge Kaya, Berkan Karabuğa, et al. · Pharmaceuticals
Distinct NGS mutational landscape and prognostic implications in early-onset colorectal cancer: A dual-cohort analysis of TCGA PanCancer Atlas and MSK-IMPACT 50K
2026 · Elif Sertesen Çamöz, Osman Bilge Kaya, et al. · PLoS ONE
PDF
Absolute Survival Benefit of Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer: A Reconstructed Individual Patient Data Re-analysis of RASolute 302
2026 · Kaya, Osman Bilge, Karabuğa, Berkan, et al. · Zenodo (CERN European Organization for Nuclear Research)
Pathway-integrated genomic analysis of papillary renal cell carcinoma in the WHO 2022 era: cell cycle pathway alterations as an independent adverse prognostic marker-a dual-cohort study
2026 · Elif Sertesen Çamöz, Cengiz Karaçin · Anatolian Current Medical Journal
PDF
Analysis code for "Complex-specific SWI/SNF alterations in hepatocellular carcinoma and clear cell renal cell carcinoma converge on mutational burden but diverge in immune phenotype and prognosis"
2026 · Sertesen Çamoz, Elif · Zenodo (CERN European Organization for Nuclear Research)
Prognostic impact of the Gustave Roussy Immune score in metastatic renal cell carcinoma treated with first-line immunotherapy-based combinations: results from the Turkish Oncology Group Kidney Cancer Consortium (TKCC)
2026 · Aysun Fatma Akkuş, Hatice Bölek, et al. · BMC Cancer
Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers: National, Comparative, Observational Study ( TOG / GI ‐ SAFRADJU ‐2501)
2026 · Erman Akkus, Mehmet Kayaalp, et al. · International Journal of Cancer
Works count: 45
Citation count: 102
H-index: 5
I10-index: 4
Year
Topic
Type